Ping Yang

Ping Yang


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
Jingan LiJingan Li
Jingan Li
FWFeng Wu
Feng Wu
KZKun Zhang
Kun Zhang
ZHZikun He
Zikun He
DZDan Zou
Dan Zou
NHNan Huang
Nan Huang

3 August 2024 in Acta Biomaterialia
Verified
Journal Article
Closed access
SDSheng Dai
Sheng Dai
LYLi Yao
Li Yao
LLLuying Liu
Luying Liu
JCJiawei Cui
Jiawei Cui
ZSZhaogui Su
Zhaogui Su
PYPing Yang
Ping Yang

1 May 2014 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
JLJingan Li
Jingan Li
KZKun Zhang
Kun Zhang
HCHuiqing Chen
Huiqing Chen
TLTao Liu
Tao Liu
PYPing Yang
Ping Yang
NHNan Huang
Nan Huang

29 April 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
CHCongzhen Han
Congzhen Han
XLXiao Luo
Xiao Luo
DZDan Zou
Dan Zou
Jingan LiJingan Li
Jingan Li
KZKun Zhang
Kun Zhang
NHNan Huang
Nan Huang
Functionalizing cardiovascular biomaterials with an extracellular matrix (ECM) via in vitro decellularization has been applied as an effective method to improve the biocompatibility of implants. However, the current ECM modified materials used for surface engineering implants have functional restrictions compared with the natural blood vessel due to distinguished cell phenotypes in vitro. Herein, we are inspired by the natural vascular basement membrane which is composed of an ECM secreted by physiological endothelial cells (EC) and smooth muscle cells (SMC), preparing a novel ECM coating by successive cell culture and decellularization: appropriately scaled hyaluronic acid (HA) micro-patterns are used to regulate the SMC phenotype to contraction and simulate the blood flow shear stress (BFSS) effect to control the EC physiological phenotype. The nature-inspired ECM coating significantly improves the material's hemocompatibility, cytocompatibility and tissue compatibility, and may be promising to break the function limitation of a single ECM and address more clinical complications.

1 April 2015 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
JLJingan Li
Jingan Li
KZKun Zhang
Kun Zhang
JWJuejue Wu
Juejue Wu
LZLijuan Zhang
Lijuan Zhang
PYPing Yang
Ping Yang
NHNan Huang
Nan Huang

2 January 2024 in Regenerative Biomaterials
Verified
Journal Article
Open access
PDF file
SDSheng Dai
Sheng Dai
LJLang Jiang
Lang Jiang
LLLuying Liu
Luying Liu
ZSZhaogui Su
Zhaogui Su
LYLi Yao
Li Yao
NHNan Huang
Nan Huang
Poor wound healing in diabetics is primarily caused by persistently high levels of inflammation and recurrent bacterial infections. The catalytic therapy technique based on nanozyme medicine has emerged as a beacon of hope for patients with diabetic wounds. However, the use of a single-atom nanozyme may still have limitations, including nanozyme burst release, immunological clearance, and insufficient antibacterial activity. To address the aforementioned problems, we provide a new nano-catalytic therapeutic agent for diabetic skin ulcers that incorporates a single-atom nanozyme with high antioxidant activity into a metal-organic framework (ZIF-Cu/C-dots). First, a Cu single-atom nanozyme supported by ultra-small carbon dots (Cu/C-dots) with high antioxidant activity was created. A nanozyme-integrated metal-organic framework was then created, utilizing Cu/C-dots as ligands and Zn2+ as the core metal. Cu/C-dots have good oxidase-like activity, shielding the biological system from ROS damage and reducing the expression of TNF-α and IL-1β. Zn2+ also has good antibacterial activity (the antibacterial rate was more than 90%). This integrated technique prevents nanozyme aggregation, improves nanozyme biocompatibility, slows down the breakdown of ZIF, and allows for the regulated release of Cu/C-dots and Zn2+ as needed. Finally, in vivo studies have shown that ZIF-Cu/C-dots can effectively alleviate inflammation at the site of diabetic wounds, accelerate vascular regeneration, promote collagen deposition, and enhance tissue remodeling, serving as a novel nano-catalytic platform for the treatment of wounds that are difficult to heal.